Skip to main content

Table 4 Baseline and treatment-related predictors of total ASES score at week 104, based on univariate models

From: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis

Variable

Coefficient (95% CI)

p-value

Variable

Coefficient

p-value

Clinical/demographic

  

IPQ-R

  

 Age

0.01 (0.00, 0.02)

0.056

 Illness coherence

0.09 (0.06, 0.13)

<0.001

 Gender (male)

0.36 (0.06, 0.66)

0.021

 Treatment control

0.11 (0.05, 0.17)

<0.001

 Ab-status (+)

−0.03 (−0.37, 0.31)

0.856

 Personal control

0.08 (0.04, 0.12)

<0.001

 Erosive disease (+)

0.14 (−0.19, 0.46)

0.409

 Emotional repr.

−0.09 (−0.11, −0.07)

<0.001

 RDCI

−0.05 (−0.17, 0.07)

0.442

 Consequences

−0.09 (−0.13, −0.06)

<0.001

 Treatment type

0.00 (−0.11, 0.10)

0.981

UCL

  

 Treatment response

−0.51 (−0.66, −0.36)

<0.001

 Seeking social support

0.04 (0.00, 0.08)

0.065

 HAQ

−0.57 (−0.76, −0.37)

<0.001

 Passive reacting

−0.11 (−0.15, −0.06)

<0.001

 DAS28-CRP

−0.07 (−0.18, 0.04)

0.222

 Active tackling

0.05 (0.01, 0.09)

0.028

 PGA (VAS)

−0.13 (−0.19, −0.07)

<0.001

 Palliative reacting

−0.02 (−0.06, 0.02)

0.364

 TJC28

−0.01 (−0.03, 0.02)

0.543

 Avoidance

−.04 (−0.08, 0.01)

0.093

 SJC28

0.01 (−0.01, 0.04)

0.356

 Expr. of emotion

−0.03 (−0.11, 0.05)

0.484

 CRP

0.00 (−0.01, 0.00)

0.108

 Reassuring thoughts

0.02 (−0.04, 0.08)

0.504

 ESR

0.00 (−0.01, 0.01)

0.782

SF-36

  

 PhGA (VAS)

−0.09 (−0.16, −0.02)

0.021

 MCS

0.41 (0.29, 0.53)

<0.001

 Pain (VAS)

−0.12 (−0.18, −0.06)

<0.001

 VT

0.25 (0.19, 0.32)

<0.001

 Fatigue (VAS)

−0.14 (−0.20, −0.09)

<0.001

 SF

0.16 (0.11, 0.21)

<0.001

RAQoL

  

 MH

0.27 (0.20, 0.34)

<0.001

 RAQoL

−0.07 (−0.09, −0.05)

<0.001

 RE

0.09 (0.06, 0.12)

<0.001

  1. Results were obtained from univariate linear regression models predicting the total ASES score at week 104. For this exploratory stage, no correction for multiple comparisons was applied
  2. ASES Arthritis Self-Efficacy Scale, RDCI Rheumatic Diseases Comorbidity Index, HAQ Health Assessment Questionnaire, DAS28-CRP Disease Activity Score in 28 joints with C-reactive protein, PGA patient’s global assessment of disease activity, TJC28 tender joint count in 28 joints, SJC28 swollen joint count in 28 joints, CRP C-reactive protein, ESR erythrocyte sedimentation rate, PhGA physician’s global assessment of disease activity, VAS visual analogue scale, SF-36 Short-Form 36, MCS mental component score, VT vitality, SF social function, MH mental health, RE Role Emotional, IPQ-R Revised Illness Perception Questionnaire, UCL Utrecht Coping List